Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential applications. Preliminary findings suggest that this higher dosage may enhance the drug's ability to regulate blood sugar, potentially offering more significant outcomes for individuals with insulin resistance. Further investigation is underway to ful